Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

Non-FDG PET Tracers in Oncology

Nov. 29, 4:30-6:00 p.m. | S505AB

This session covers a range of topics related to the latest developments in radiotracers. It offers a review of major biological targets that could be useful for imaging in prostate and other cancers, and showcases the potential of a variety of non-FDG tracers.

Screening for Diseases: Current Controversies

Wednesday, Nov. 28, 4:30-6:00 p.m. | E450A

A panel of expert speakers reviews the benefits, harms and controversies associated with screening for lung and breast cancer.

Essentials in Oncologic Imaging: What Radiologists Need to Know: Part II

Wednesday, Nov. 28, 2:00-5:45 p.m. | S402AB

This interactive, case-based session provides a practical, clinically-relevant summary of key imaging issues in common cancers , includes an overview of current cancer-related terminology and describes how imaging can optimally assess and measure tumor treatment response.

Advanced Imaging Techniques for Detection and Staging of Prostate Cancer

Wednesday, Nov. 28, 10:30 a.m. – 12:15 p.m. | E353C

Speakers discuss a wide variety of topics, including various MRI techniques and the role of imaging in active surveillance of prostate cancer.

Essentials in Oncologic Imaging: What Radiologists Need to Know: Part I

Wednesday, Nov. 28, 8:30 a.m. – 12:15 p.m. | S402AB

This interactive, case-based session provides a practical, clinically-relevant summary of key imaging issues in common cancers , includes an overview of current cancer-related terminology and describes how imaging can optimally assess and measure tumor treatment response.

Essentials in Oncologic Imaging: What Radiologists Need to Know: Part I

Wednesday, Nov. 28, 8:30 a.m. – 12:15 p.m. | S402AB

This interactive, case-based session provides a practical, clinically-relevant summary of key imaging issues in common cancers , includes an overview of current cancer-related terminology and describes how imaging can optimally assess and measure tumor treatment response.

Blood hormone levels predict breast cancer risk for up to 20 years

A single blood hormone measurement in postmenopausal women can predict the risk of hormone-receptor positive breast cancer for up to 20 years. The findings may be integrated into breast cancer risk prediction models.

Beyond the pink: Are we there yet?

October, National Breast Cancer Awareness Month, typically brings a bevy of pink ribbons, t-shirts and more. This year, the color pink seems to have exploded. It’s a marketing success story, but will it translate into actions that make a difference?

Displaying 6209 - 6216 of 23561

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.